Are These 3 Penny Stocks on Your Watchlist in 2021?
With a rather bullish start to the trading day for both penny stocks and blue chips, there are hundreds of options for your watchlist. But, when it comes to making a penny stocks watchlist, there are a few things that all investors should understand. First and foremost is having a thorough understanding of what’s going on in the stock market. Right now, this includes Covid and specifically the Omicron variant as well as high inflation.
Both of these factors are impacting the entire stock market, and continue to create high volatility. While a volatile market may seem scary at first, this is often something that investors look for as it presents opportunities to make money in the short term. So, with this in mind, let’s take a look at three penny stocks to watch right now.
3 Penny Stocks to Watch in December 2021
Alset EHome International Inc. (NASDAQ: AEI)
Alset EHome International Inc. is a company that works in the real estate development industry. Its services include home building, land development, sales, and many others. The company also creates apps for enterprise e-commerce platforms. Also worth noting is that Alset has a division dedicated to nutritional chemistry research in order to develop a natural sugar substitute. Only a week or so ago, AEI stock took a major dive, falling by around 44% in just a day. Since then, shares have remained relatively stable with small gains incrementally.
On December 2nd, Alset completed the seeding of its first 30 rental homes to American Home REIT. This was completed by its Singapore Exchange-listed majority-owned subsidiary Alset International Limited. Alset International Limited aspires to build AHR into a Class A portfolio of income-producing, high-yielding real estate in the United States, with an emphasis on big gated single-family home communities. AHR proposes to pay a quarterly dividend with an annualized yield of up to 6% on assets with a capitalization rate of around 5% on net operating income.
“It has been our organization’s mission to develop a sustainable healthy living ecosystem, and AHR was strategically established as one of the key driving factors in this journey. Having successfully completed the seeding of our first 30 residential assets, AHR is well on its way to generating a steady flow of recurring income that will fuel our overall growth plans in the years moving forward.”
The Chairman and CEO of Alset, Mr. Chan Heng Fai
On December 8th, the company then closed a $30 million underwritten public offering of common stock. Amid all of this recent info, will AEI be on your penny stock watchlist?
Ardelyx Inc. (NASDAQ: ARDX)
Ardelyx Inc. is a biotech penny stock that we have discussed at length several times in the past few weeks. And in the past month, shares of ARDX stock have shot up by a very respectable, 32%. If you’re not familiar, Ardelyx is a corporation that develops kidney and cardiorenal disease-based drugs. Ardelyx is involved in the development and marketing of these compounds and is working on building out its portfolio of products. Tenapanor, the company’s flagship candidate, recently completed Phase 3 clinical trials for the treatment of constipation in individuals with irritable bowel syndrome.
On November 30th, The company announced its plans to introduce IBSRELA. IBSRELA is an FDA-approved therapy for adults with IBS and constipation. This approved treatment will be available in the second quarter of 2022. The company is still working with the FDA to get tenapanor approved for hyperphosphatemia through the formal dispute resolution process.
“Over the last five years, the IBS-C market has grown to be sizeable and concentrated, with 9,000 high-writing physicians accounting for approximately 50% of the almost five million prescriptions written annually for drugs indicated for the treatment of IBS-C.”
President and CEO of Ardelyx, Mike Raab
One month ago, ARDX stock was at $1.20 per share, and it has now reached $1.58 per share as of December 10th. Based on this new momentum, will ARDX be on your penny stock watchlist?
Progenity Inc. (NASDAQ: PROG)
Progenity Inc. is a biotech penny stock that has recently increased in price. From September 28th to November 16th, shares of PROG stock shot up by an incredible 440%. This is a major gain and one that we do not often see in the stock market. For some context, Progenity is a company that develops molecular testing products. Progenity recently gained recognition for its COVID-19 PCR testing services, which have remained popular over the last year and a half or so. Progenity also sells testing products for gene diseases including Lynch syndrome.
On December 2nd, Progenity announced a new patent for a single-molecule detection therapy. This is U.S. Patent No. 11,186,863 titled “Methods, Systems, and Compositions for Counting Nucleic Acid Molecules”. This patent covers critical methods for counting target molecules, obviating the need for sequencing. The company currently has a strong patent portfolio related to its single-molecule detection platform which has helped to bring in more popularity to Progenity overall. This includes six patent families covering different aspects of Progenity’s programs.
“Our Single-Molecule Detection Platform is designed to enable tests such as noninvasive prenatal testing (NIPT) or liquid biopsy for cancer to be performed without the need for costly, complex sequencing, which would greatly reduce cost and simplify operational implementation. The platform also has potential applications beyond nucleic acids, such as proteins.”
The General Manager of Diagnostics at Progenity, Matthew Cooper
Up 2.2% on December 9th, will PROG be on your list of penny stocks to watch in 2021?
Can Penny Stocks Show Profitability This Month?
If you’re looking for the best penny stocks to buy, there are hundreds of options to choose from. But, it’s not as simple as picking a handful of stocks and investing.
Rather, investors should understand both the ins and outs of the company as well as what is going on in the world that is causing momentum. With all of that in mind, do you think that penny stocks can continue to show profitability this month?